Richard F. Pops is recorded as Board Member at Alkermes plc. (ALKS) since January 1, 2011. The newest filing on record that lists Richard F. Pops as Board Member at Alkermes plc. (ALKS) is dated April 6, 2026. Alkermes plc. reported in an 8-K filed February 25, 2026 that Richard F. Pops retired as Chief Executive Officer, effective July 31, 2026. Alkermes plc. reported in an 8-K filed May 31, 2024 a re-election or new board role (director) for Richard F. Pops, on the board since at least 2011, effective May 31, 2024. The proxy statement of Alkermes plc. reports total compensation of $7,915,081 for Richard F. Pops in fiscal 2025, including a base salary of $1,250,769. Disclosed compensation is on record for 9 fiscal years. Richard F. Pops has spoken on 25 earnings calls and 2 other investor events across 1 company, most recently for Alkermes plc. on June 10, 2026. Alkermes plc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alkermes plc. includes Blair C. Jackson (CEO, CFO and COO), Mr. Richard F. Pops (CEO), Iain M. Brown (CFO and Chief Accounting Officer) and 7 others.
“On February 24, 2026, Richard F. Pops, Chairman and Chief Executive Officer of Alkermes plc (the "Company"), notified the Company's board of directors (the "Board") of his decision to retire from his position of Chief Executive Officer, effective July 31, 2026, following a distinguished 35 years of service in this role.”
Alkermes plc. Form 8-K, filed February 25, 2026
· Read the filing
“By separate resolutions, shareholders elected the following directors, each to serve for a one-year term expiring at the Company’s 2025 annual general meeting of shareholders, or until their respective successor is elected and shall qualify, with the votes cast as follows:”
Alkermes plc. Form 8-K, filed May 31, 2024
· Read the filing
Richard F. Pops on recent calls
“Well, thanks for having us, first of all. And standing room only in this giant room.”
“So we had an excellent financial first quarter with another strong period of commercial execution and business performance. The quarter was consequential in other ways.”
“Well, we clearly had a strong and eventful 2025. As we enter 2026, there are three elements of the business to understand and to value, and the first is the commercial business.”
“So Alkermes delivered a strong third quarter. It was marked by solid commercial execution, significant progress in our development pipeline, robust financial performance and continued execution across our strategic priorities.”
